Anti-TLR3/ CD283/ IIAE2 functional antibody

Anti-TLR3/ CD283/ IIAE2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TLR3/TLR3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T67894-Ab-1/ GM-Tg-hg-T67894-Ab-2Anti-Human TLR3 monoclonal antibodyHuman
GM-Tg-rg-T67894-Ab-1/ GM-Tg-rg-T67894-Ab-2Anti-Rat TLR3 monoclonal antibodyRat
GM-Tg-mg-T67894-Ab-1/ GM-Tg-mg-T67894-Ab-2Anti-Mouse TLR3 monoclonal antibodyMouse
GM-Tg-cynog-T67894-Ab-1/ GM-Tg-cynog-T67894-Ab-2Anti-Cynomolgus/ Rhesus macaque TLR3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T67894-Ab-1/ GM-Tg-felg-T67894-Ab-2Anti-Feline TLR3 monoclonal antibodyFeline
GM-Tg-cang-T67894-Ab-1/ GM-Tg-cang-T67894-Ab-2Anti-Canine TLR3 monoclonal antibodyCanine
GM-Tg-bovg-T67894-Ab-1/ GM-Tg-bovg-T67894-Ab-2Anti-Bovine TLR3 monoclonal antibodyBovine
GM-Tg-equg-T67894-Ab-1/ GM-Tg-equg-T67894-Ab-2Anti-Equine TLR3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T67894-Ab-1/ GM-Tg-hg-T67894-Ab-2; GM-Tg-rg-T67894-Ab-1/ GM-Tg-rg-T67894-Ab-2;
GM-Tg-mg-T67894-Ab-1/ GM-Tg-mg-T67894-Ab-2; GM-Tg-cynog-T67894-Ab-1/ GM-Tg-cynog-T67894-Ab-2;
GM-Tg-felg-T67894-Ab-1/ GM-Tg-felg-T67894-Ab-2; GM-Tg-cang-T67894-Ab-1/ GM-Tg-cang-T67894-Ab-2;
GM-Tg-bovg-T67894-Ab-1/ GM-Tg-bovg-T67894-Ab-2; GM-Tg-equg-T67894-Ab-1/ GM-Tg-equg-T67894-Ab-2
Products NameAnti-TLR3 monoclonal antibody
Formatmab
Target NameTLR3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TLR3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T67894-Ag-1Recombinant multi-species TLR3/ CD283/ IIAE2 protein


    Target information

    Target IDGM-T67894
    Target NameTLR3
    Gene ID7098,142980,364594,574378,482905,493661,281535,100009703
    Gene Symbol and SynonymsCD283,IIAE2,IMD83,TLR3
    Uniprot AccessionO15455,Q5TJ59
    Uniprot Entry NameTLR3_HUMAN,TLR3_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseCancer
    Gene EnsemblENSG00000164342
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: TLR3, gene name: TLR3, also named as CD283, IIAE2. The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.